Experimental group (n = 58) | Control group (n = 58) | P value | |
---|---|---|---|
Duration of stimulation (days) | 10.12 ± 2.28 | 10.0 ± 1.50 | 0.76 |
No. of used antagonist ampoule | 10.12 ± 2.28 | 3.93 ± 1.32 | < 0.0001* |
Total ampoules of used gonadotropins (75 IU) | 47.2 ± 12.7 | 43.7 ± 10.4 | 0.11 |
Serum estradiol on HCG day | 524 ± 78.29 | 358± 51.21 | 0.23 |
Serum progesterone on HCG day | 0.61 ± 0.37 | 0.52 ± 0.28 | 0.17 |
Serum LH level on HCG day | 2.60± 3.14 | 3.23± 5.66 | 0.52 |
No. of retrieved oocytes | 4.17 ± 2.89 | 3.20 ± 2.47 | 0.07 |
No. of metaphase II oocytes | 3.35 ± 2.55 | 2.46 ± 2.20 | 0.04* |
Fertilization rate | 0.77 ± 0.24 | 0.79 ± 0.25 | 0.5 |
No. of obtained embryo | 2.61 ± 1.45 | 2.13± 1.47 | 0.17 |
No. of top quality embryos | 1.68 ± 1.63 | 1.37± 1.41 | 0.30 |
Cycle cancelation rate; n (%) | 5/84 (5.9) | 2/74 (2.7) | 0.43 |
No. of embryos transferred | 2.20 ± 0.67 | 1.73 ± 1.08 | 0.13 |
Endometrial thickness on ET day (mm) | 9.34 ± 1.14 | 9.08 ± 0.98 | 0.19 |
Implantation rate | 0.58 ± 0.39 | 0.33 ± 0.28 | 0.36 |
Clinical pregnancy rate per ET (%) | 40% | 11.1% | 0.02* |
Miscarriage rate per ET (%) | 6.6% | 3.9% | 0.53 |
Ongoing pregnancy rate per ET (%) | 33.4% | 7.2% | 0.03* |